Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Chronic Obstructive Pulmonary Disease Age: Adult |
Dose: Inhaled solution – 175 mcg Frequency: once daily Note: Administer by mouth (oral) via nebulizer using a mouthpiece at the same time every day. Not to exceed 175 mg once daily. |
|
Indication: Chronic Obstructive Pulmonary Disease Age: Adult Condition: Hepatic impairment |
Dose: Inhaled solution – 175 mcg Note: Mild-to-severe: Safety not evaluated; not recommended in patients with any degree of hepatic impairment. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: dosage - No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Any degree of impairment |
Dose: Not mentioned Note: No dosage adjustment is required |
|
Indication: COPD Condition: Severe renal impairment |
Dose: Not mentioned Note: Monitor for systemic antimuscarinic adverse effects |
Administration
- For inhalation only
- Use with nebulizer
Side Effect
- Cough (4%)
- Nasopharyngitis (4%)
- Headache (4%)
- Upper respiratory tract infection (URTI) (3%)
- Back pain (2%)
- Hypertension (1-2%)
- Dizziness (1-2%)
- Oropharyngeal pain (1-2%)
- Bronchitis (1-2%)
- Paradoxical bronchospasm
- Worsening narrow-angle glaucoma
- Worsening urinary retention
- Immediate hypersensitivity reactions
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Anticholinergic drugs
|
May have additive effects
|
|
OATP1B1 and OATP1B3 inhibitors
|
May increase systemic exposure of revefenacin's active metabolite
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.